A Phase 1/2 Study of Dendrimer-Enhanced (DEP) SN38 (SN38-SPL9111/DEP Irinotecan) in Patients with Advanced Solid Tumours

Jia Liu,Anna R. Minchom, Alastair Greystoke, Thomas R. J. Evans,Debashis Sarker, Anthony M. Joshua,Cienne Morton, Aisha Gaus, Wing Yau,Rasha Cosman, Dominika Chwialkowska,Jeremy R. A. Paull, Bernadette M. Jean-Francois,Jacinth K. Fairley, Nicola J. Main,Stephanie R. Edmondson,Natalie Cook

MOLECULAR CANCER THERAPEUTICS（2023）

Cited 0|Views7

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined